Abacavir
( DrugBank: Abacavir / KEGG DRUG: Abacavir sulfate, Abacavir )
4 diseases
2. 筋萎縮性側索硬化症
臨床試験数 : 786 / 薬物数 : 550 - (DrugBank : 182) / 標的遺伝子数 : 170 - 標的パスウェイ数 : 232
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
135. アイカルディ症候群
臨床試験数 : 2 / 薬物数 : 12 - (DrugBank : 4) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 37
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
265. 脂肪萎縮症
臨床試験数 : 127 / 薬物数 : 137 - (DrugBank : 58) / 標的遺伝子数 : 28 - 標的パスウェイ数 : 99
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
325. 遺伝性自己炎症疾患
臨床試験数 : 12 / 薬物数 : 15 - (DrugBank : 7) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 37
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|